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Background: Gestational Diabetes Mellitus (GDM) increases risks for type 2 diabetes and weight management is
recommended to reduce the risk. Conventional dietary recommendations (energy-restricted, low fat) have limited
success in women with previous GDM. The effect of lowering Glycaemic Index (GI) in managing glycaemic variables
and body weight in women post-GDM is unknown.
Objective: To evaluate the effects of conventional dietary recommendations administered with and without additional
low-GI education, in the management of glucose tolerance and body weight in Asian women with previous GDM.
Method: Seventy seven Asian, non-diabetic women with previous GDM, between 20- 40y were randomised into
Conventional healthy dietary recommendation (CHDR) and low GI (LGI) groups. CHDR received conventional dietary
recommendations only (energy restricted, low in fat and refined sugars, high-fibre). LGI group received advice on
lowering GI in addition. Fasting and 2-h post-load blood glucose after 75 g oral glucose tolerance test (2HPP) were
measured at baseline and 6 months after intervention. Anthropometry and dietary intake were assessed at baseline,
three and six months after intervention. The study is registered at the Malaysian National Medical Research Register
(NMRR) with Research ID: 5183.
Results: After 6 months, significant reductions in body weight, BMI and waist-to-hip ratio were observed only in LGI
group (P<0.05). Mean BMI changes were significantly different between groups (LGI vs. CHDR: -0.6 vs. 0 kg/m2, P= 0.03).
More subjects achieved weight loss ≥5% in LGI compared to CHDR group (33% vs. 8%, P=0.01). Changes in 2HPP were
significantly different between groups (LGI vs. CHDR: median (IQR): -0.2(2.8) vs. +0.8 (2.0) mmol/L, P=0.025). Subjects
with baseline fasting insulin≥2 μIU/ml had greater 2HPP reductions in LGI group compared to those in the CHDR
group (−1.9±0.42 vs. +1.31±1.4 mmol/L, P<0.001). After 6 months, LGI group diets showed significantly lower GI (57±5
vs. 64±6, P<0.001), GL (122±33 vs. 142±35, P=0.04) and higher fibre content (17±4 vs.13±4 g, P<0.001). Caloric intakes
were comparable between groups.
Conclusion: In women post-GDM, lowering GI of healthy diets resulted in significant improvements in glucose
tolerance and body weight reduction as compared to conventional low-fat diets with similar energy prescription.
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History of gestational diabetes mellitus (GDM) is a non-
modifiable risk factor for developing type 2 diabetes
mellitus (T2DM) [1,2]. Frequently, women with prior
GDM exhibit tendencies for central obesity, insulin resist-
ance and glucose intolerance [3]. Thirty-three to 50% of
GDM women develop overt T2DM five years after delivery
[4]. At ten years postpartum, 35–60% of GDM women are
known to develop type 2 DM [3]. Hence GDM represents
a challenging group to institute effective intervention [5].
Intensive lifestyle intervention has shown to be effect-
ive in reducing risk for T2DM in high risk individuals
[6,7]. Conventional diets for primary prevention of
T2DM consistently support energy-restricted, low-fat,
and high–complex carbohydrate regime to achieve
weight loss [8,9]. However, such interventions have
shown limited success in reducing postpartum weight
in women after GDM [10].
Meanwhile, emerging evidence emphasizes the role of
insulin secretion and insulin resistance in body weight
regulation [11]. Therefore, dietary factors that influence
these parameters would include the type of carbohydrate
defined by its glycaemic index (GI) and its overall gly-
caemic potential described by its glycaemic load (GL, i.e.
sum of the product of GI and available carbohydrate
amounts for all foods consumed in the diet [12]) are
known to modulate weight loss, especially in hyper-
insulinaemic women [13,14]. Low GI diets also improve
glycaemic control in Asian diabetics [15] and reduce risk
for T2DM [16]. However the effect of lowering dietary GI
in women with prior GDM is currently unknown. This
study aimed to evaluate the effect of adding low GI dietary
advice to conventional dietary prescription on glycaemic
variables and body weight in comparison to conventional
dietary prescription among women with previous GDM.
Methods
This study was conducted at the endocrine clinic of a ter-
tiary hospital. The project was approved by the Ethic and
Research Review Committees of the institutions involved,
in-line with national regulations and according to the
International Harmonization Consensus on Good Clinical
Practice. The study is registered at the Malaysian National
Medical Research Register with Research ID: 5183. The
trial was carried out according to Consolidated Standards
of Reporting Trials (CONSORT) guidelines.
Inclusion and exclusion criteria
Healthy women in the age group of 20–40 years old,
with a history of GDM (defined according to WHO cri-
teria, [17]), and high risks for developing T2DM were in-
cluded. While GDM itself is a non-modifiable risk factor
for T2DM, certain modifiable risk factors that increase
the risk in this group of subjects have been identified.These include central obesity, higher postpartum body
mass index (BMI), fasting blood sugar (FBS), 2 h post-
load blood glucose (2HPP) and energy intake [18,19].
Hence preventive interventions would be especially
beneficial to subjects who have high risks as indentified
by the inclusion criteria of the study. We therefore de-
fined high risk as satisfying one of the following four
conditions: BMI>23 kg/m2, or waist circumference>
80 cm [20], or impaired glucose tolerance (IGT) defined
as 2HPP after 75 g screening oral glucose tolerance test
(OGTT) ≥7.8 and<11.1 mmol/L or impaired fasting glu-
cose (IFG) defined as FBS>5.6 mmol/L or a family his-
tory of T2DM. Exclusion criteria were the diagnosis of
T2DM (FBS≥7.0 mmol/L, or 2HPP≥11.1 mmol/l, [17],
or presence of other health complications and usage of
drugs affecting body weight and glucose control. Written
informed consent was obtained from all participants.
The women were enrolled into the trial at a minimum
of two months after their last GDM delivery.
Measurement of outcome variables
The primary end point of this study was 2HPP after a
75 g oral glucose tolerance test was administered. FBS,
fasting serum insulin (INS) and anthropometric mea-
sures were the secondary endpoints investigated.
Body weight rounded to 0.1 kg was measured in light
clothing, after emptying pockets and without footwear,
using digital weighing scales (Model: BWB-800A, Tanita
Corporation, Tokyo, Japan). Height without footwear was
measured using the wall mounted stadiometer (Model No.
206, SECA, Hamburg, Germany), rounded to 0.1 cm to
calculate BMI. BMI was calculated as the ratio of weight
in kg to the square of height in m2. Waist and hip circum-
ference in cm was measured as per WHO guidelines [21]
and waist-to-hip ratio was calculated. All anthropometric
measurements were done by a single researcher to avoid
bias. Anthropometric measurements were made at base-
line, three and six months after intervention.
Blood samples were collected after a 12-h fasting, and
analysed for FBS and insulin. A 75 g OGTT was adminis-
tered and 2HPP samples were obtained. Blood glucose was
analysed using the G6PD/Hexokinase method as per rou-
tine medical centre laboratory protocol. Serum samples for
INS were frozen at −20°C until batch processed for analysis.
INS was analysed with chemiluminescent enzyme-labelled
immunometric assay, using Immulite 2000 automated ana-
lyser (Diagnostic Products Corporation, Los Angeles, USA).
Blood glucose and INS values were measured at baseline
and 6 months after intervention.
Dietary intake was assessed with 3-day dietary records.
The subjects were asked to report intake for any 2 week-
days and one weekend day for each visit. Subjects were
trained to use the diet records at the screening visit and
pictures of household measures were provided to assist
Shyam et al. Nutrition Journal 2013, 12:68 Page 3 of 12
http://www.nutritionj.com/content/12/1/68the subjects with recording the amounts. Diet records
were collected at baseline, three and six months after
intervention. All food records were reviewed with sub-
jects during their follow up visits by the research nutri-
tionist to ensure completeness of entries.
GL by definition is the “product of the GI of foods and
its carbohydrate content” [22]. GL for individual food
items in the dietary record was calculated as the product
of diet GI and carbohydrate intake divided by 100 [23].
Dietary GL represents both the quantity and the quality of
carbohydrate in diet [22] and was calculated as sum total
of GL of foods consumed in the day [24]. Diet GI was cal-
culated using the formula Diet GI= Diet GL×100/amount
of carbohydrate in the diet [24].
A Microsoft Excel-based food composition database and
diet intake calculator- “DietPLUS Version 3” was built for
this study and was used for dietary analysis [25]. Due to
lack of availability of local GI values, GI values for numer-
ous Malaysian foods needed to be matched or estimated.
Hence a systematic GI value assignment to foods in the
Malaysian food composition table to similar foods pub-
lished internationally was undertaken. To improve the ac-
curacy of this GI-matching process, the GI assignment
was based on previously published methodology [26]. The
international GI and GL database and its updated version
the online database of University of Sydney was used
for this purpose [27,28]. The methodology of adding
glycaemic index and glycaemic load functionality to the
Malaysian food composition database has been previously
published [25].
International Physical activity short Questionnaire
(IPAQ-short) was used to assess physical activity levels
of the subjects [29].Randomisation
All eligible subjects (n=77) were randomized strictly
according to a computerized allocation (1:1) list generated
using randomisation software [30]; by an individual from
outside this research group. The researchers were unaware
of the sizes of blocks used. Participants were randomized
to either a conventional healthy dietary recommendation
(CHDR) or the “CHDR+Low GI” group (LGI).Dietary intervention
Details on the educational intervention and tools used have
been published earlier [31]. However for the sake of com-
pleteness a brief description is provided here. The aim
of the nutrition education was to achieve and maintain a
5-7% reduction in body weight if BMI>23 and maintain
current weight if BMI<23 during the one year complete
trial period. The nutrition intervention aimed to achieve
this objective through establishing two diets that weresimilar in energy and macronutrient content but with dif-
ferent dietary GI. Individual energy requirement was calcu-
lated by multiplying basal metabolic rate (BMR) by an
appropriate activity factor [32] based on reported physical
activity pattern and occupation. Harris Benedict method
was used to calculate BMR [32]. If the subject had a
BMI>23 and if she was not breast feeding, the energy pre-
scription was reduced by 500 Kcal. Subjects with BMI< 23
or those breastfeeding an infant<6 mo of age were pre-
scribed their energy requirement (energy prescribed=energy
requirement). All EP was rounded to the nearest hundred.
Energy prescription was capped at 1800 Kcal/day. Each
subject was given an individualized dietary sheet with the
recommended number of servings of each food group per
day according to their energy prescription. Subjects were
taught meal planning based on their individualized energy
prescription and a sample one day menu was provided dur-
ing the intervention visit. Concepts of serving size, number
of servings and food exchange groups were taught to both
groups of subjects. These dietary prescriptions were indica-
tive in nature as the study subjects were “out-patients” and
intervention was educational in nature.
Primary nutrition educational intervention was admin-
istered through a structured one-to-one session with the
research nutritionist, at baseline. Conceptual guidance to
achieve conventional recommended diet (CHDR) low in
fat and refined sugars, and high in fibre was provided
using the 5M framework proposed by the Malaysian
Ministry of Health ( minimize salt, sugar, oil, more fruit
and vegetables) [33]. Subjects were encouraged to in-
dulge in moderate physical activity for 30min, at least
five times a week.
The LGI group in addition to the above conventional
recommendations also received a GI-education compo-
nent that taught subjects to substitute high GI foods with
low GI options. Staple foods primarily determine dietary
GI [34], hence, GI-education focused on the strategies to
select low-GI options for high GI rice, bread and breakfast
cereals. Subjects were advised to restrict rice intake to
once per day since most locally available rice varieties were
high in GI [35]. They were encouraged to choose lower GI
foods like spaghetti, noodles or multi-grain bread at other
times. Subjects were not required to memorize numerical
GI values of foods. However a list of foods that classified
foods as high, moderate or low GI was provided to aid
making choices. The LGI subjects were asked to include
one low GI food at each meal.
Colour coded (pink for LGI and blue for CHDR) take-
home booklets were also provided to the subjects as added
reference. To improve retention of participants in the trial
two electronic interactions (short messaging service (SMS)
or e-mail, as per the subject’s preference) per month was
established. These contacts were similar between the
groups in terms of frequency and content of delivery.
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Sample size was calculated to detect at the end of one year,
a 1.5 mmol/L difference in the postprandial blood glucose,
the primary end point for this study. This difference is
thought to be of clinical significance [36] between the diet
treatments, with a power of 80%. This was based on the
assumption that the standard deviation of the response
variable is 1.5 mmol/L [37]. A total of 34 subjects, 17 per
group, were required for this study. Taking into account
the higher attrition rates in preventive trials [38], and
reported reluctance among women post-GDM to partici-
pate [5], we started with a bigger sample size.
Statistical analysis
Statistical analyses were performed using IBM SPSS (Ver-
sion 19, Somers, NY, USA). The effect of the respective
dietary interventions on anthropometric measurements
and glycaemic variables at the end of 6 months was inves-
tigated. Primary analysis included intent to treat analysis
of anthropometric data and glycaemic variables. Missing
data was imputed conservatively with the last observation
carried forward technique. A secondary analysis was car-
ried out using the completers’ analysis. For the dietary data
analysis the baseline values and a mean of the intake at
three and six months visit was used. A sub-analysis to de-
termine the differential response to the dietary interven-
tion in subjects with varying fasting insulin levels was
carried out. Fasting insulin value of 2 μIU/ml was chosen
to be the cut-off for this analysis since it was approxi-
mately the natural median INS value for our subjects
The statistical significance standard was set at 5%. Data
normality was tested using the Shapiro–Wilks test. Data is
presented as Mean ± SD, unless stated otherwise. Differ-
ences between groups were assessed using independent
samples t test and changes in outcomes before and after
intervention were analysed using paired t tests. When the
test assumptions were not met, Mann–Whitney U-test
test for two samples was used to compare values between
groups and Wilcoxon Sign test was used to compare the
changes in outcome within the group. Effect size values
were computed to compare the effects of the diet treat-
ments [14]. Effect sizes between 0.2-0.5, 0.5-0.8 and >0.8
were taken to denote “small”, ”moderate” and “large”
changes in outcomes [14].
Linear regression analysis was used to study the role of
energy intake, macronutrient intakes, dietary fibre, GI and
GL as predictor variables on changes in body weight. In
modelling 2HPP, in addition to the above mentioned pre-
dictors (dietary variables), change in body weight was in-
cluded. In modelling FBS, in addition to dietary variables
mentioned above, changes in body weight and 2HPP were
included. A sub-analysis was done grouping subjects with
INS<2 μIU/L and ≥2 μIU/L in studying the models as
attempted above. We also wanted to test if the effect of GIon 2HPP was mediated by changes in weight, among the
subjects with INS≥2 μIU/L. In this test the Sobel’s Method
was used [39].
Results
Seventy-seven subjects were recruited out of whom a total
of 62 (29 in CHDR and 33 in LGI group) completed the
6 months on the trial (refer to Figure 1). The two groups
had comparable baseline characteristics as shown in
Table 1.
Changes in anthropometry
Intent to treat (ITT) analysis showed significant reduc-
tions from baseline to six months in body weight
(P=0.018), BMI (P=0.008), waist circumference (P<0.001)
and waist-hip-ratio (P=0.02) in LGI group. In CHDR
group there was a significant reduction in waist circumfer-
ence (P=0.048) only (Refer Table 2). The effect sizes for
the changes in weight, BMI, waist circumference and
waist-hip-ratio from baseline to six months in the LGI
group were 0.40, 0.45, 0.70 and 0.38, respectively which
are moderate to large. The effect sizes for the changes in
the same variables in the CHDR group were merely 0.02,
0.02, 0.33 and 0.22, respectively.
As shown in Figure 2, a greater number of subjects
achieved a percentage weight loss≥5% in LGI as com-
pared to CHDR Group (33% vs. 8%, P=0.01)
Changes in glycaemic variables
The subjects had normoglycaemia or dysglycaemia (im-
paired fasting glucose/ impaired glucose tolerance) as
tested by 75 g OGTT at baseline. FBS and 2HPP levels in
the two groups were comparable at baseline (See, Table 3).
From baseline to 6 months, the changes in fasting blood
sugar were not significant in both groups (See, Table 3).
There was no significant change in median 2HPP in the
LGI group (−0.2 (IQR: 2.8) mmol/L, P= 0.960). In the
CHDR group, there was a significant increase in median
2HPP (+0.8 (IQR: 2.0) mmol/L, P=0.01). The changes in
2HPP were significantly different between groups (P=0.025,
See, Table 3).
Results obtained from per-protocol analysis for changes
in anthropometric and glycaemic outcomes were similar
to the respective analysis done using ITT (data for per-
protocol analysis not shown here).
Baseline glucose tolerance status and response to dietary
treatment
The anthropometric and glycaemic changes among sub-
jects varying in baseline glucose tolerance status are
shown in the following Table 4. There was a slight increase
in weight and 2HPP blood glucose among subjects with
dysglycaemia in CHDR group but in the LGI group there
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Figure 1 Diagram of the flow of participants. Legend: CHDR: Group receiving Conventional Healthy Dietary Recommendations Only: Low GI:
Group receiving Conventional Healthy Dietary Recommendations +Low GI education, ITT: intent-to-treat analysis.
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CHDR (n= 3/8) and 64.3% in LGI (n=9/14) reverted to
normoglycaemia (RR: 1.5, P= 0.378).Fasting insulin levels and response to dietary treatment
Out of the 77 subjects, 44 (57.1%) had INS<2 μIU/L and
33 (42.9%) had INS≥2 μIU/L. The percentage of sub-
jects with INS<2 μIU/L in the LGI and CHDR groups
were 61.5 and 52.6% respectively. This difference be-
tween the groups was not significant (P=0.228).
Among the subjects with INS<2 μIU/L, there was no
significant difference in the anthropometric and gly-
caemic changes for both LGI and CHDR groups (data
not shown).
As shown in Figure 3, among subjects with baseline
INS≥2 uIU/ml the percentage weight loss was higher inthe LGI group compared to the CHDR group (−3.1% vs. +
0.2%, P=0.09).
For 2HPP, LGI subjects with baseline INS≥2 μIU/ml,
recorded a significant reduction (−1.9±0.42 mmol/L,
P=0.002) while the 2HPP levels increased (1.31± 1.4,
P=0.004) among similar subjects in the CHDR group
(See Figure 4). The level of 2HPP changes between the
groups was significant (P <0.001). A sizable increase
in 2HPP levels among subjects with baseline
INS≥2 μIU/ml, was noted among those in the highest
GI quartile (P value for trend =0.019, See Figure 5).
There was no significant association between GI and
changes in 2HPP among subjects with baseline INS<2
μIU/ml (P=0.576, See Figure 5).
Changes in FBS were however not significant within
or between diet groups in such subjects (data
not shown).
Table 1 Baseline characteristics of subjects (Mean±SD)
Characteristic LGI CHDR P1 Value
Age (y) 30.9±4.3 31.5±4.5 0.999
No. of Pregnancies* 2±2 2±1 0.245
No. of GDM Pregnancies* 1±0 1±1 0.891
Parity* 2±2 2±2 0.671








BMI (kg/m2) 26.4±4.6 26.3±4.6 0.952
% subjects with BMI>23
(Overweight)
74.4 71.1 0.802
% subjects with BMI>25 59 63.2 0.816
% subjects with BMI>27.5 (Obese) 38.5 47.5 0.494
% subjects breast feeding 10.3 21.1 0.420
Waist Circumference (cm) 83.2±8.5 82.7±9.6 0.789





Fasting blood glucose(mmol/L) 4.7±0.54 4.8±0.53 0.405
2 h post 75 g OGTT blood
glucose (mmol/L)
6.8±1.6 6.2±1.4 0.067
Legend: LGI Low GI Group, CHDR Conventional healthy Dietary
Recommendation Group.
*Expressed as median±interquartile range, P1 Value: test between groups.
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Food records were collected from the subjects at baseline,
at 3 months and at 6 months. Food records from 34 sub-
jects in LGI group and 31 subjects in CHDR group were
used in the analysis. The results of the dietary analysis are
presented in Table 5. The after intervention values are the
average between three and six month values.
Baseline dietary intakes were comparable between
groups. In the LGI group, mean percentage of calories
from carbohydrate, amount of carbohydrates, diet GI
and GL decreased significantly from baseline, while per-
centage of energy from protein and dietary fibre in-
creased significantly. The only significant dietary change
from baseline in the CHDR group was the reduction in
the percentage of energy from fat. After six months,
mean percentage of calories from carbohydrate, GI and
GL were significantly lower in the LGI compared to the
CHDR group. Fibre intake was significantly higher in theTable 2 Anthropometric outcomes during the course of the s
Outcome LGI
baseline 3 months 6 mo
Weight (Kg) 65.3±11.5a 64.6±11.5b 64.0±1
BMI(kg/m2) 26.4±4.6a 26.0±4.7a 25.8±
WC (cm) 83.2±8.5 a 83.0±10.4b 80.5±
WHR 0.81±0.06a 0.80 ±0.06 0.79 ±
Legend: LGI Low GI Group, CHDR Conventional healthy Dietary Recommendation G
For each group, values in a row with similar alphabetical superscripts show significaLGI group. During the study period, only changes in
dietary glycaemic index and dietary fibre intakes were
significantly different between groups (Refer Table 5).
Based on the results from regression analysis, mean GL
during the six months after intervention was the single in-
dependent predictor of weight loss in subjects (R2= 13.5%,
standardized B= 0.37, P= 0.003). Weight change was the
single independent predictor of changes in 2HPP (R2=
7.4%, standardized B= 0.272, P= 0.02). Change in 2HPP
was the independent predictor of change in FBS (R2=32.
7%, standardized B= 0.572 P< 0.001).
In subjects with INS≥2 μIU/L, mean GI primarily
explained changes in 2HPP mean (R2=43. 8%, standard-
ized B= −0.662 P< 0.001), with reduction in 2HPP being
caused by a reduction in GI. Further analysis with block
regression showed that mean GI explained 43.8% of the
change in 2HPP while weight change explained only an
additional of 3.9% (P=0.227) in these subjects. The Sobel’s
method was used to further determine if the effect of GI
on 2HPP was mediated through changes in weight. The
results showed that mediation effect was small and not
significant in subjects with INS≥2 μIU/L (Indirect effect
vs. Direct effect: unstandardized B= −0.05 vs. 0.196,
P values 0.716 vs. <0.001).
Physical activity and adherence
Physical activity levels remained comparable between the
groups at baseline (LGI vs. CHDR: median (IQR):608
(2727) vs. 900(2304) MET.min/week, P=0.143) and at the
end of six months study period (933 (1403) vs.965 (857)
MET.min/week, P= 0.908). Dietary adherence (self reported
and calculated, data not shown here) were statistically com-
parable between the groups.
Discussion
The current study was designed to investigate the effects
of adding low-GI nutrition education to conventional
healthy dietary advice in subjects with previous history of
GDM. Baseline characteristics were well matched in terms
of socio-demographic and metabolic variables. Subjects in
the LGI group of this study lost an average of 1.3 kg com-
pared to the 0.1 kg loss in the CHDR arm, after six
months on the trial. These findings are in agreement with
the Cochrane review which concluded that subjects ontudy (Mean±SD)
CHDR
nths baseline 3 months 6 months
1.7ab 64.6±12.5 64.7±12.6 64.5±13.0
4.7a 26.3±4.6 26.4±4.7 26.3±4.8
9.1ab 82.7±9.6 a 82.5±10.8 81.5±10.1a
0.05a 0.80±0.05 0.80±0.05 0.79±0.05
roup, BMI Body mass index, WC waist circumference WHR waist hip ratio.
ntly different means in paired tests.
Figure 2 Percentage weight loss in study groups. Legend: LGI: Low GI Group, CHDR: Conventional healthy Dietary Recommendation Group, P
value shown is calculated between the percentage of subjects in both groups using Fischer’s Exact test.
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high GI diets, in trials that lasted up to 6 months in dur-
ation [40]. In this study, more post-GDM subjects in LGI
group achieved a moderate 5% weight loss (P=0.01).
Hence, low GI diets aid weight loss in the study popula-
tion of women with previous GDM as compared to con-
ventional healthy diets with similar energy prescriptions,
during a 6 month period.
Moderate weight loss in the range of 5-10% has been
proven to improve cardio-metabolic risk in high risk sub-
jects [41]. Furthermore, every 1 kg weight reduction
achieved in the first year of the Diabetes Prevention Pro-
gram (DPP) translated into a 16% reduction in risk for
conversion to T2DM [42]. Hence by promoting moderate
weight loss in the group of post-GDM subjects, LGI diets
may contribute effectively to lowering their cardio-
metabolic risks.
CHDR subjects had a significant increase of 0.6 mmol/L
from the baseline 2HPP levels, after six months’ interven-
tion. The magnitude of this change described by its effect
size is “moderate” and remains a cause for concern in
GDM women who are known to be at an increased risk
for development of glucose intolerance [3]. Therefore,
conventional healthy diets that emphasize on calorie andTable 3 Changes from baseline in glycaemic values (Mean±SD
LGI
Baseline 6 months
FBS (mmol/L) 4.7±0.53 5.0±1.2
ΔFBS (mmol/L)* −0. 2 (0.6)
2HPP (mmol/L) 6.8±1.6 6.8±2.8
Δ2HPP (mmol/L)* −0.2 (2.8) a
Legend: LGI Low GI Group, CHDR Conventional healthy Dietary Recommendation G
OGTT. P1: Significance of changes within groups.
* Data presented as median (interquartile range).
a Difference between groups significant (P=0.025).fat control do not benefit these women with prior GDM,
in terms of improving glucose tolerance.
The LGI group, on the contrary, had maintained their
2HPP levels during the same period of study. As an in-
crease in 2HPP predominantly represents glucose in-
tolerance [17], lowering of 2HPP within these subjects
by LGI diet would lead to the reduction of the preva-
lence of abnormal glucose tolerance. This line of thought
finds further support in the higher rate of reversal to
normoglycaemia observed among IGT subjects in LGI
group after six months (50% vs. 40%, P= 0.689.). Fur-
thermore, post-challenge plasma glucose spikes are
thought to be more strongly associated with risk for ath-
erosclerosis than FBS in a cohort at risk for diabetes
[43]. Hence, the improvement in glucose tolerance could
delay or prevent the subsequent development of T2DM
and its complications in this high risk group of subjects.
There is a paucity of data on the normal fasting insulin
range for young healthy Malaysian women. A Malaysian
study among 30 healthy volunteers reported a median
fasting insulin level of 4.7 μIU/ml with a central 95%
range of 2.1 to 12.1 μIU/ml [44]. Baseline INS in 18/38
subjects in CHDR group and 15/39 subjects in LGI
group were <2 μIU/ml. Given that women with prior)
CHDR
P1 Baseline 6 months P1
0.060 4.8±0.53 4.9±0.53 0.111
0.1(0.6)
0.960 6.2±1.4 6.8±1.6 0.010
0.8 (2.0)a
roup. FBS Fasting blood sugar, 2HPP 2 hour post load blood glucose after 75 g
Table 4 Anthropometric and glycaemic changes in subjects with varying glucose tolerance status during the six
months study period (Mean±SD)
Baseline glucose tolerance status Normoglycaemia Dysglycaemic subjects
Outcome changes CHDR LGI P CHDR LGI P
Weight (kg) −0.2±2.72 −1.93±3.48* 0.446 0.5±2.97 −0.7±3.37 0.446
BMI (kg/m2) −0.08±1.04 −0.76±1.41* 0.077 0.25±1.2 −0.6±1.54 0.230
WC (cm) −1.33±3.34 −3.72±4.24** 0.046 −2.14±4.53 −2.67±3.66* 0.786
WHR −0.01±0.04 −0.02±0.005 0.427 −0.02±0.05 −0.03±0.03* 0.282
FBS (mmol/L) 0.15±0.41 0.31±0.53* 0.290 0.04±0.45 0.49±1.7 0.507
2HPP (mmol/L) 0.88±1.2*** 0.24±2.04 0.216 0.47±2.22 −0.49±4.05 0.572
Legend: LGI Low GI Group, CHDR Conventional healthy Dietary Recommendation Group. BMI Body mass index, WC waist circumference, WHR waist hip ratio,
FBS Fasting blood sugar, 2HPP 2 hour post load blood glucose after 75g OGTT.
P values show the significance of difference in changes between groups.
Values with asterisks denote significant changes in paired-tests, *P≤0.05, **P≤0.01, ***P≤0.001.
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http://www.nutritionj.com/content/12/1/68GDM have innate tendencies towards insulin resistance
[45], one would expect our study population to have
higher fasting insulin levels. It was unexpected that 57%
of our subjects would have INS less than the 2.1 μIU/ml.
However, Farhan et al., (2012) also found the mean fasting
insulin values, of a small group (n=10) of Austrian GDM
women, at 3 month postpartum to be 1.63 μIU/ml. One
possible explanation for this occurrence is that only 43% of
our subjects could be classified as being obese (BMI>27.5)
[46], which could have resulted in the normoglycaemic
state represented in the fasting blood glucose and normal
or low INS. The median BMI of this study group was 26,
and hence these subjects could be defined only as being
mildly overweight based on the WHO criteria [47]. This
finding suggests that despite their inherent insulin resist-
ance accentuated by pregnancy, these subjects were at a
very early stage of pre-diabetes, making early detection and
intervention necessary if not paramount. We acknowledge
that a large cross sectional study of healthy Malaysian indi-
viduals is necessary to determine normal reference fasting
insulin range for this population.
The dietary intervention resulted in significant differ-
ent outcomes in subjects with baseline INS≥2 μIU/mlFigure 3 Percentage weight loss among subjects categorized by base
Conventional healthy Dietary Recommendation Group, P values for significwith respect to anthropometry and 2HPP. For subjects
with baseline INS≥2 μIU/ml the greatest improvement
in glucose tolerance was noted among subjects in the low-
est quartile for dietary GI at 6 months. Furthermore these
subjects also achieved more weight loss when on LGI di-
ets. These findings are consistent with the 6 months find-
ing from the CALERIE study which reported that women
with higher postprandial insulinaemic response lost more
weight on low GI diets after 6 months on intervention
[14]. However the mean baseline fasting insulin levels in
the CALERIE subjects was 11.9 μIU/ml, which was much
higher than the mean for this study group.
Additionally, among subjects with higher baseline INS,
the LGI group observed a significant reduction in the
2HPP while the 2HPP levels increased in the CHDR group.
This difference in 2HPP changes between groups was sta-
tistically significant (Mean Δ(LGI-CHDR) =2.4 mmol/L,
P=0.004). Since interventions that reduced 2-h plasma glu-
cose by >0.84 mmol/L are thought to halve the risk for
incidence of T2DM [36], LGI diets may be highly
recommended for post-GDM women with higher fasting
insulin levels. Furthermore, in subjects with INS≥2 μIU/L
the reduction in 2HPP brought about by lowering dietaryline fasting insulin levels. Legend: LGI: Low GI Group, CHDR:
ance of changes between the diet groups are shown.
Figure 4 2H Post-75g oral glucose load blood glucose changes among subjects categorized by baseline fasting insulin (mmol/L).
Legend: LGI: Low GI Group, CHDR: Conventional healthy Dietary Recommendation Group, P values for significance of changes between the diet
groups are shown.
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http://www.nutritionj.com/content/12/1/68GI was not primarily mediated through body weight loss.
This mechanism of action is of special interest in post-
GDM women, who have little success in attaining moder-
ate weight loss compared to other high risk groups [1].
The favourable anthropometric and glycaemic responses
to low GI intervention in those with higher insulin levels
(as against low or normal insulin secretors) can be
explained by the exaggerated responses to increase in GI
demonstrated among hyperinsulinaemic (insulin resistant)
subjects [14]. While we do not possess the postprandial
insulin values for our subjects to classify them as having
typical hyperinsulinaemic response to a glucose challenge,
an increase in fasting insulin concentrations is also associ-
ated with lower liver insulin clearance, which conserves
insulin and contributes to hyperinsulinaemia [48]. Recent























Quartile 4 (Highest) Quartile 3
Figure 5 Baseline fasting insulin levels and 2HPP changes among die
< 2 uIU/L, High INS subjects with Baseline fasting INS ≥ 2 uIU/ml. Quartilesmay have varying effects depending on individual meta-
bolic functioning of the “adipo-insular axis” [49].
A trend for increasing weight and 2HPP blood glucose
was observed in subjects with dysglycaemia within the
CHDR group. Furthermore a higher likelihood of conver-
sion to normoglycaemia among dysglycaemic subjects was
observed in the LGI group. In the current trial, 37.5% and
64.3% of subjects with dysglycaemia at baseline, returned
to normoglycaemia at 6 months in CHDR and LGI groups
respectively. The percentage of dysglycaemic subjects
returning to normoglycaemia in the LGI arm of our study
was comparable to the results from lifestyle intervention
in China that also used acarbose and metformin [50].
Hence, LGI diets could be more effective in managing gly-
caemia among hyperinsulinaemic, dysglycaemic women
with a previous history of GDM.High INS
Quartile 2  Quaritle 1(Lowest)
tary GI quartiles. Legend: Low INS: subjects with Baseline fasting INS
refer to dietary GI quartiles at 6 months.
Table 5 Dietary intake of subjects before and after intervention (Mean ± SD)
Dietary outcome LGI CHDR P values for
difference in changes
between groups
Baseline After intervention P1 Baseline After intervention P1
Calories 1804±495 1660±368 0.075 1721± 491 1612±352 0.171 0.970
CHO g 245±75 206±52 0.002 225±68 220±48 0.627 0.224
CHO en% 55±9 51±5** 0.050 53±7 55±7** 0.240 0.065
Protein g 66±21 69±15 0.323 70±26 63±21 0.119 0.191
Protein en% 15±4 20±6 <0.001 16±5 19±7 0.124 0.400
Fat g 62±23 58±18 0.418 60±20 53±16 0.064 0.695
fat en% 29±8 28±5 0.368 30±6 25±7 0.004 0.177
Dietary Fibre (g) 13±5 17±4*** 0.001 13±5 13±4*** 0.583 0.022
Glycaemic Index 62±5 57±5*** 0.003 62±7 64±6*** 0.4 0.033
Glycaemic Load 152±41 122±33* <0.001 142±42 141±35* 0.854 0.085
LGI Low GI Group, CHDR Conventional Healthy Dietary Recommendation Group.
P1- P values for changes within groups.
*Values significantly different between groups - (P<0.05), **Values significantly different between groups (P=<0.01).
***Values significantly different between groups (P=<0.001).
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http://www.nutritionj.com/content/12/1/68We acknowledge the following limitations to the study.
This study is limited by the fact that the dietary intake
including GI and GL were calculated based on reported
intakes, though attempts were made to ensure complete-
ness of reporting. The 3-day food record was chosen to
evaluate dietary data. This was done so since this tool is
the least intrusive of diet recording techniques and was
hence best suited to this group of subjects with many
recognized barriers to participate in preventive interven-
tions [5]. To improve the accuracy of the reporting, sub-
jects were trained to use the three day food records at
the screening visit and assisted by illustrations of house-
hold measures to aid in recording amounts consumed.
Secondly, fifty- two percent of the subjects were identi-
fied as under-reporters based on a EI:BMR<1.2, [51]) at
baseline. However, these observations were within the
estimates for prevalence of under-reporting among over-
weight and obese women [52]. Furthermore, the per-
centage of under-reporters in LGI and CHDR groups
were comparable between groups (p=0.405). Further-
more, excluding the under-reporters did not alter the
statistical significance observed in the dietary intake
among subjects. Food records also do not capture details
of food processing and other factors affecting dietary
variables, including GI. Nevertheless, outcome changes
in the LGI and CHDR groups were consistent with pre-
vious reports for similar dietary intake comparisons
[34,35], thereby adding credence to the dietary data
obtained from the subjects.
Self-reported dietary data are considered acceptable as
indicators of dietary quality including percentage contri-
bution to energy from macronutrients [53]. Dietary GI,
being a measure of quality could also be expected to be
minimally affected by underreporting. However, it is feltthat underreporting may have also contributed to the
smaller differences in GL observed between the groups.
It is also acknowledged that the clinically significant
10 point difference in dietary GI between the groups
[54], could not be achieved after 6 months of interven-
tion. Also the dietary GI for the LGI group was actually
in the intermediate GI category (diet GI less than sixty
[16]). However, more subjects in LGI had intermediate
GI (62 vs. 21%), while more subjects in the CHDR
group were in the high GI category (79 vs. 37%). Asian
trials that achieved comparable difference in GI of
around six units between groups, have also documented
significant beneficial effects in terms of reductions in
waist circumference, fasting blood sugar and glycaemic
control in diabetic subjects or those with impaired
fasting glucose [34,35]. This study was able to demon-
strate that moderate reductions in GI of seven units had
beneficial effects on the anthropometric and 2HPP out-
comes of Asian post-GDM women with postpartum
normoglycaemia, IFG or IGT.
We concede that neither group reached the universal
25-30 g dietary fibre intake recommendation. Achieving
this target in the Malaysian environment has been rec-
ognized as a challenge [55]. However, it should be noted
that LGI group had a significantly higher fibre intake as
compared to the CHDR group in this study (17 vs. 13 g,
P<0.001). Thus, adding GI education to CHDR improved
dietary fibre intakes in subjects which could not be
achieved with CHDR. Such additional benefits in dietary
quality when using low GI diets in the Asian population
has also been documented earlier [56].
We do not possess formal data on satisfaction of the
subjects with the two dietary interventions. However, self-
reported adherence and calculated adherence to energy
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http://www.nutritionj.com/content/12/1/68and fat intake prescriptions and drop-out rates were com-
parable between the groups. Thus it may be appropriate to
consider that acceptance to both interventions may also
be similar.
The assay employed to measure INS samples in this
study, failed to analyse samples with INS <2 μIU/ml. Hence
the INS cut-off used to group subjects to conduct the sub-
analysis to investigate the differential effect of the diets in
subjects with varying insulin levels can be considered arbi-
trary. However, the varied metabolic response to the two di-
ets provides a strong evidence for the added benefit of
lowering GI for subjects with higher insulin levels.
Conclusions
This six months intervention study showed that lower-
ing the dietary GI of conventional diets improved glu-
cose tolerance and reduced body weight, in comparison
to the conventional diet in women with previous history
of GDM. Subjects with higher fasting insulin level in the
low GI group demonstrated the most positive effects in
the improvement of their dysglycaemia and weight loss.
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